Largest Unscheduled Dip Buys
Insider purchases made after significant recent stock price declines.
10% Owner at Sequans Communications ($SQNS) purchased 12,300 shares at $5.12/share ($62.97K total), which increased their listed holdings by 0.01%. This is their 16th largest purchase out of 26 all time. This insider has made 6 total purchases at this company in the last 30 days. Appears to be a regularly scheduled weekly transaction. Buying the dip (stock was down -32.34% in the three months before the purchase).
(SEC Source)
Largest Unscheduled Purchases
The largest insider purchases not part of scheduled trading plans or 10% owner activity.
Director at Vivani Medical, Inc. ($VANI) purchased 1,351,351 shares at $1.48/share ($2.00M total), which increased their listed holdings by 4.31%. This is their 5th largest purchase out of 68 all time. 2 insiders have made 3 total purchases at this company in the last 30 days. Is part of a purchase agreement.
(SEC Source)
Chief Financial Officer at Ally Financial Inc. ($ALLY) purchased 11,566 shares at $43.17/share ($499.31K total), which increased their listed holdings by 5.26%. This is their 2nd largest purchase out of 3 all time. 2 insiders have made 2 total purchases at this company in the last 30 days.
(SEC Source)
Director at Amerant Bancorp Inc. ($AMTB) purchased 4,816 shares at $20.99/share ($101.08K total), which increased their listed holdings by 963.20%. This is their 3rd largest purchase out of 3 all time.
(SEC Source)
Director at Norwood Financial Corp. ($NWFL) purchased 3,500 shares at $28.80/share ($100.80K total), which increased their listed holdings by 57.72%. This is their 2nd largest purchase out of 2 all time. 2 insiders have made 2 total purchases at this company in the last 30 days.
(SEC Source)
Largest Unscheduled Sales
The largest insider sales not part of scheduled trading plans or 10% owner activity.
CEO and Chairman of the Board at Johnson & Johnson ($JNJ) sold 100,000 shares at $221.23/share ($22.12M total), which decreased their listed holdings by -24.52%. This is their 2nd largest sale out of 4 all time.
(SEC Source)
Vice Chairman at Interactive Brokers Group, Inc. ($IBKR) sold 155,000 shares at $75.84/share ($11.76M total), which decreased their listed holdings by -25.54%. This is their 4th largest sale out of 156 all time. This insider has made 2 total sales at this company in the last 30 days.
(SEC Source)
President and CEO at Protagonist Therapeutics, Inc. ($PTGX) sold 48,273 shares at $84.18/share ($4.06M total), which decreased their listed holdings by -5.23%. This is their 2nd largest sale out of 11 all time. 3 insiders have made 6 total sales at this company in the last 30 days. Selling the rip (stock was up 117.33% in the year before the sale).
(SEC Source)
Chief Financial Officer at Protagonist Therapeutics, Inc. ($PTGX) sold 46,203 shares at $83.13/share ($3.84M total), which decreased their listed holdings by -26.27%. This is their 1st largest sale out of 4 all time. 3 insiders have made 6 total sales at this company in the last 30 days. Selling the rip (stock was up 117.33% in the year before the sale).
(SEC Source)
Chief Legal & Compliance Officer at United Parcel Service Inc. ($UPS) sold 25,014 shares at $106.15/share ($2.66M total), which decreased their listed holdings by -52.14%. This is their 3rd largest sale out of 9 all time.
(SEC Source)
Chief Medical Officer at Protagonist Therapeutics, Inc. ($PTGX) sold 23,151 shares at $82.30/share ($1.91M total), which decreased their listed holdings by -13.36%. This is their 1st largest sale out of 4 all time. 3 insiders have made 6 total sales at this company in the last 30 days. Selling the rip (stock was up 117.33% in the year before the sale).
(SEC Source)
Chief Financial Officer at Truist Financial Corp. ($TFC) sold 13,000 shares at $50.13/share ($651.66K total), which decreased their listed holdings by -11.43%. This is their 1st largest sale out of 5 all time.
(SEC Source)
EVP & CFO at Adobe Inc. ($ADBE) sold 1,646 shares at $294.85/share ($485.32K total), which decreased their listed holdings by -2.31%. This is their 11th largest sale out of 11 all time.
(SEC Source)
Chief Experience Officer at Live Oak Bancshares, Inc. ($LOB) sold 9,700 shares at $39.01/share ($378.35K total), which decreased their listed holdings by -15.07%. This is their 1st largest sale out of 1 all time.
(SEC Source)
Director at First Western Financial Inc. ($MYFW) sold 4,406 shares at $25.11/share ($110.65K total), which decreased their listed holdings by -7.30%. This is their 5th largest sale out of 9 all time.
(SEC Source)
Largest Purchases by Percent Change
The insider sales that reduced ownership the most on a percentage basis.
Director at Amerant Bancorp Inc. ($AMTB) purchased 4,816 shares at $20.99/share ($101.08K total), which increased their listed holdings by 963.20%. This is their 3rd largest purchase out of 3 all time.
(SEC Source)
President and CEO at Zivo Bioscience, Inc. ($ZIVO) purchased 11,709 shares at $8.54/share ($99.99K total), which increased their listed holdings by 148.05%. This is their 1st largest purchase out of 2 all time. 4 insiders have made 4 total purchases at this company in the last 30 days. Buying the dip (stock was down -42.55% in the three months before the purchase). Large price difference: Current: $9.75 | Tx: $8.54 | Diff: (+14.17%).
(SEC Source)
Director at Norwood Financial Corp. ($NWFL) purchased 3,500 shares at $28.80/share ($100.80K total), which increased their listed holdings by 57.72%. This is their 2nd largest purchase out of 2 all time. 2 insiders have made 2 total purchases at this company in the last 30 days.
(SEC Source)
Director at SmartFinancial, Inc. ($SMBK) purchased 255 shares at $39.38/share ($10.04K total), which increased their listed holdings by 33.25%. This is their 1st largest purchase out of 1 all time.
(SEC Source)
Largest Sales by Percent Change
The insider sales that reduced ownership the most on a percentage basis.
Chief Legal & Compliance Officer at United Parcel Service Inc. ($UPS) sold 25,014 shares at $106.15/share ($2.66M total), which decreased their listed holdings by -52.14%. This is their 3rd largest sale out of 9 all time.
(SEC Source)
Chief Technology Officer at Robinhood Markets, Inc. ($HOOD) sold 5,864 shares at $107.48/share ($630.28K total), which decreased their listed holdings by -39.10%. This is their 7th largest sale out of 19 all time. 3 insiders have made 4 total sales at this company in the last 30 days. Is part of a 10b5-1 plan. Selling the rip (stock was up 124.85% in the year before the sale).
(SEC Source)
Chief Accounting Officer at Accenture plc ($ACN) sold 3,588 shares at $281.01/share ($1.01M total), which decreased their listed holdings by -30.49%. This is their 2nd largest sale out of 7 all time. 8 insiders have made 11 total sales at this company in the last 30 days. Is part of a 10b5-1 plan. Appears to be a regularly scheduled yearly transaction.
(SEC Source)
EVP Global Services & Strategy at F5, Inc. ($FFIV) sold 3,343 shares at $261.87/share ($875.43K total), which decreased their listed holdings by -29.32%. This is their 4th largest sale out of 58 all time. This insider has made 5 total sales at this company in the last 30 days. Is part of a 10b5-1 plan. Appears to be a regularly scheduled weekly transaction.
(SEC Source)
President and COO at United Therapeutics Corp. ($UTHR) sold 30,375 shares at $470.03/share ($14.28M total), which decreased their listed holdings by -26.42%. This is their 1st largest sale out of 45 all time. 4 insiders have made 14 total sales at this company in the last 30 days. Is part of a 10b5-1 plan. Appears to be a regularly scheduled monthly transaction.
(SEC Source)
Chief Financial Officer at Protagonist Therapeutics, Inc. ($PTGX) sold 46,203 shares at $83.13/share ($3.84M total), which decreased their listed holdings by -26.27%. This is their 1st largest sale out of 4 all time. 3 insiders have made 6 total sales at this company in the last 30 days. Selling the rip (stock was up 117.33% in the year before the sale).
(SEC Source)
Vice Chairman at Interactive Brokers Group, Inc. ($IBKR) sold 155,000 shares at $75.84/share ($11.76M total), which decreased their listed holdings by -25.54%. This is their 4th largest sale out of 156 all time. This insider has made 2 total sales at this company in the last 30 days.
(SEC Source)
CEO and Chairman of the Board at Johnson & Johnson ($JNJ) sold 100,000 shares at $221.23/share ($22.12M total), which decreased their listed holdings by -24.52%. This is their 2nd largest sale out of 4 all time.
(SEC Source)
10% Owner at Zevia PBC ($ZVIA) sold 3,500,000 shares at $2.00/share ($7.00M total), which decreased their listed holdings by -20.53%. This is their 6th largest sale out of 7 all time.
(SEC Source)
10% Owner at NET Power Inc. ($NPWR) sold 295,220 shares at $2.37/share ($699.93K total), which decreased their listed holdings by -19.05%. This is their 15th largest sale out of 23 all time. This insider has made 3 total sales at this company in the last 30 days. Appears to be a regularly scheduled monthly transaction.
(SEC Source)
President and COO at United Therapeutics Corp. ($UTHR) sold 14,625 shares at $464.66/share ($6.80M total), which decreased their listed holdings by -17.18%. This is their 22nd largest sale out of 44 all time. 4 insiders have made 14 total sales at this company in the last 30 days. Is part of a 10b5-1 plan. Appears to be a regularly scheduled monthly transaction.
(SEC Source)
Chief Experience Officer at Live Oak Bancshares, Inc. ($LOB) sold 9,700 shares at $39.01/share ($378.35K total), which decreased their listed holdings by -15.07%. This is their 1st largest sale out of 1 all time.
(SEC Source)
Chief Medical Officer at Protagonist Therapeutics, Inc. ($PTGX) sold 23,151 shares at $82.30/share ($1.91M total), which decreased their listed holdings by -13.36%. This is their 1st largest sale out of 4 all time. 3 insiders have made 6 total sales at this company in the last 30 days. Selling the rip (stock was up 117.33% in the year before the sale).
(SEC Source)
EVP & General Counsel / Corp. Secretary at ExlService Holdings, Inc. ($EXLS) sold 8,114 shares at $42.53/share ($345.09K total), which decreased their listed holdings by -13.17%. This is their 4th largest sale out of 18 all time. Is part of a 10b5-1 plan.
(SEC Source)
CEO – The Americas at Accenture plc ($ACN) sold 3,986 shares at $276.38/share ($1.10M total), which decreased their listed holdings by -12.77%. This is their 4th largest sale out of 7 all time. 8 insiders have made 11 total sales at this company in the last 30 days. Is part of a 10b5-1 plan.
(SEC Source)
SVP – Chief Operating Officer at Midland States Bancorp, Inc. ($MSBI) sold 2,808 shares at $22.67/share ($63.66K total), which decreased their listed holdings by -11.75%. This is their 1st largest sale out of 1 all time. Selling the rip (stock was up 41.5% in the three months before the sale).
(SEC Source)
Chief Leadership & HR Officer at Accenture plc ($ACN) sold 787 shares at $280.79/share ($220.98K total), which decreased their listed holdings by -11.55%. This is their 1st largest sale out of 2 all time. 8 insiders have made 11 total sales at this company in the last 30 days. Is part of a 10b5-1 plan.
(SEC Source)
Chief Financial Officer at Truist Financial Corp. ($TFC) sold 13,000 shares at $50.13/share ($651.66K total), which decreased their listed holdings by -11.43%. This is their 1st largest sale out of 5 all time.
(SEC Source)
Director at Airbnb, Inc. ($ABNB) sold 58,000 shares at $133.28/share ($7.73M total), which decreased their listed holdings by -11.14%. This is their 89th largest sale out of 98 all time. 2 insiders have made 4 total sales at this company in the last 30 days. Is part of a 10b5-1 plan. Appears to be a regularly scheduled monthly transaction.
(SEC Source)
EVP & Chief Medical Officer at Intuitive Surgical Inc. ($ISRG) sold 230 shares at $532.61/share ($122.50K total), which decreased their listed holdings by -10.47%. This is their 56th largest sale out of 62 all time. 2 insiders have made 2 total sales at this company in the last 30 days. Is part of a 10b5-1 plan. Appears to be a regularly scheduled yearly transaction.
(SEC Source)
Chief Executive Officer at Travere Therapeutics, Inc. ($TVTX) sold 60,000 shares at $30.09/share ($1.81M total), which decreased their listed holdings by -10.01%. This is their 2nd largest sale out of 5 all time. 6 insiders have made 7 total sales at this company in the last 30 days. Is part of a 10b5-1 plan.
(SEC Source)
Disclaimer: The content provided by InsiderEdge™ is for informational purposes only and does not constitute investment advice, an offer to sell, or a solicitation of an offer to buy any securities. The historical performance noted in this post is not is not indicative of future results. Investing involves risk, including the potential loss of principal. Use the platform at your own risk and consult a financial advisor before making any investment decisions. In partnership with Yellowbrick Investing Inc.
